IFU
EW icon

iSAM Funds (UK)’s Edwards Lifesciences EW Stock Holding History

iSAM Funds (UK)’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Buy
12,100
+6,623
+121% +$555K 0.77% 28
2026
Q1 		$439K Sell
5,477
-2,927
-35% -$241K 0.22% 142
2025
Q4 		$716K Buy
+8,404
New +$690K 0.26% 116
2025
Q3 		– Sell
-6,115
Closed -$478K – 684
2025
Q2 		$478K Sell
6,115
-1,855
-23% -$138K 0.1% 280
2025
Q1 		$578K Buy
+7,970
New +$570K 0.29% 111
2023
Q3 		– Sell
-9,826
Closed -$927K – 266
2023
Q2 		$927K Buy
+9,826
New +$854K 0.83% 31

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

iSAM Funds (UK)'s EW Position: Q2 2026 in Review

iSAM Funds (UK) increased its Edwards Lifesciences (EW) stake by 121% in Q2 2026, buying an estimated $555K and bringing the position to 12,100 shares worth $1.09M. The position accounts for 0.77% of the portfolio, ranked #28.

iSAM Funds (UK) first reported a position in EW in Q2 2023 and has held it in 6 quarters since. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • iSAM Funds (UK) held 12,100 shares of Edwards Lifesciences worth $1.09M as of Q2 2026.
  • iSAM Funds (UK) bought 6,623 Edwards Lifesciences shares in Q2 2026, an estimated $555K.
  • Edwards Lifesciences made up 0.77% of iSAM Funds (UK)'s portfolio in Q2 2026, its #28 holding.
  • iSAM Funds (UK) first reported a position in Edwards Lifesciences in Q2 2023 and has held it in 6 quarters since.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on iSAM Funds (UK)'s 13F filing for Q2 2026, filed 12 Aug 2026.